Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (NYSE: NVO)

 
NVO Technical Analysis
5
As on 31st Jul 2025 NVO SHARE Price closed @ 47.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 123.30 & Strong Sell for SHORT-TERM with Stoploss of 126.47 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NVOSHARE Price

Open 48.96 Change Price %
High 49.30 1 Day -2.96 -5.92
Low 46.90 1 Week -19.71 -29.51
Close 47.07 1 Month -27.27 -36.68
Volume 50112598 1 Year -72.92 -60.77
52 Week High 146.91 | 52 Week Low 53.94
 
NYSE USA Most Active Stocks
FSR 0.02 0.00%
DDR 15.44 -4.46%
TWTR 53.70 0.66%
NIO 4.87 7.98%
SWN 7.11 -0.56%
BACA-U 302.00 0.67%
ENLC 14.12 -0.21%
F 11.07 1.84%
ABEV 2.18 -5.22%
BBD 2.77 0.00%
 
NYSE USA Top Gainers Stocks
TGI 257.00 888.08%
TGI 257.00 888.08%
CND-WT 0.05 400.00%
WEI 0.44 51.72%
QFTA 10.26 51.33%
MOTV 18.70 50.20%
CORR 0.03 50.00%
WE 0.50 42.86%
WE 0.50 42.86%
DMS 0.45 36.36%
 
NYSE USA Top Losers Stocks
AJX 0.01 -99.67%
AJX 0.01 -99.67%
AJX 0.01 -99.67%
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
FTEV-WS 0.60 -93.81%
 
 
NVO
Daily Charts		 NVO
Intraday Charts		 Whats New @
Bazaartrend		 NVO
Free Analysis
 
NVO Important Levels Intraday
RESISTANCE51.69
RESISTANCE50.21
RESISTANCE49.29
RESISTANCE48.38
SUPPORT45.76
SUPPORT44.85
SUPPORT43.93
SUPPORT42.45
 
NVO Forecast August 2025
Share
4th UP Forecast85.57
3rd UP Forecast73.22
2nd UP Forecast65.59
1st UP Forecast57.96
1st DOWN Forecast36.18
2nd DOWN Forecast28.55
3rd DOWN Forecast20.92
4th DOWN Forecast8.57
 
NVO Weekly Forecast
4th UP Forecast59.71
3rd UP Forecast55.66
2nd UP Forecast53.15
1st UP Forecast50.65
1st DOWN Forecast43.49
2nd DOWN Forecast40.99
3rd DOWN Forecast38.48
4th DOWN Forecast34.43
 
NVO Forecast2025
4th UP Forecast242.18
3rd UP Forecast179.61
2nd UP Forecast140.93
1st UP Forecast102.25
1st DOWN Forecast-8.11
2nd DOWN Forecast-46.79
3rd DOWN Forecast-85.47
4th DOWN Forecast-148.04
 
 
NVO Other Details
Segment EQ
Market Capital 247091216384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NVO Address
NVO
 
NVO Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NVO Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service